| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $104,925 | 1 | 14 |
Sells | $4,367,640 | 6 | 86 |
| Vu Quan Anh | Chief Financial Officer | 1 | $104,925 | 0 | $0 | $104,925 |
| RIOUX PATRICE | Acting Chief Medical Officer | 0 | $0 | 1 | $111 | $-111 |
| KLAUSNER ARTHUR J | director | 0 | $0 | 1 | $343,889 | $-343,889 |
| Anderson Raymond | director | 0 | $0 | 1 | $351,835 | $-351,835 |
| Tsuchimoto Kim R | director | 0 | $0 | 1 | $455,567 | $-455,567 |
| STARR CHRISTOPHER M | director | 0 | $0 | 1 | $659,387 | $-659,387 |
| Robinson Chandler | Chief Executive Officer | 0 | $0 | 1 | $2.56M | $-2.56M |
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, which is in phase 1 imaging and dosimetry clinical trial, a radiopharmaceutical imaging …
Over the last 12 months, insiders at Monopar Therapeutics Inc. have bought $104,925 and sold $4.37M worth of Monopar Therapeutics Inc. stock.
On average, over the past 5 years, insiders at Monopar Therapeutics Inc. have bought $93,257 and sold $21.12M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Vu Quan Anh (Chief Financial Officer) — $104,925.
The last purchase of 1,500 shares for transaction amount of $104,925 was made by Vu Quan Anh (Chief Financial Officer) on 2025‑12‑26.
| 2026-10-01 | Sale | STARR CHRISTOPHER M | director | 8,400 0.099% | $78.50 | $659,387 | -7.21% | |
| 2026-09-24 | Sale | Robinson Chandler | Chief Executive Officer | 29,056 0.3369% | $88.00 | $2.56M | -17.55% | |
| 2026-08-26 | Sale | RIOUX PATRICE | Acting Chief Medical Officer | 1 <0.0001% | $111.26 | $111 | -28.02% | |
| 2026-08-26 | Sale | Tsuchimoto Kim R | director | 4,090 0.0598% | $111.39 | $455,567 | -28.02% | |
| 2026-08-25 | Sale | Anderson Raymond | director | 3,142 0.0474% | $111.98 | $351,835 | -24.45% | |
| 2025-12-26 | Vu Quan Anh | Chief Financial Officer | 1,500 0.0228% | $69.95 | $104,925 | -2.62% | ||
| 2025-12-18 | Sale | KLAUSNER ARTHUR J | director | 5,121 0.078% | $67.15 | $343,889 | +2.20% | |
| 2025-09-24 | Sale | Tactic Pharma LLC | 10 percent owner | 550,229 7.7665% | $63.61 | $35M | -2.15% | |
| 2025-07-14 | Sale | Robinson Chandler | Chief Executive Officer | 16,800 0.2513% | $40.00 | $672,020 | +40.70% | |
| 2025-07-14 | Sale | Tsuchimoto Kim R | director | 8,904 0.1332% | $40.00 | $356,171 | +40.70% | |
| 2025-07-14 | Sale | STARR CHRISTOPHER M | director | 16,800 0.2513% | $40.00 | $672,020 | +40.70% | |
| 2025-04-02 | Sale | Tactic Pharma LLC | 10 percent owner | 33,334 0.4954% | $35.00 | $1.17M | +43.39% | |
| 2024-10-28 | Radhakrishnan Karthik | Chief Financial Officer | 1,550 0.1363% | $16.25 | $25,188 | +100.90% | ||
| 2024-06-20 | Cittadine Andrew | Chief Operating Officer | 20,508 0.107% | $0.74 | $15,254 | +609.94% | ||
| 2024-06-18 | Cittadine Andrew | Chief Operating Officer | 12,000 0.0724% | $0.86 | $10,320 | +475.36% | ||
| 2024-06-17 | Cittadine Andrew | Chief Operating Officer | 12,000 0.0758% | $0.90 | $10,799 | +451.05% | ||
| 2024-06-14 | Cittadine Andrew | Chief Operating Officer | 12,000 0.0784% | $0.93 | $11,176 | +392.98% | ||
| 2024-06-13 | Cittadine Andrew | Chief Operating Officer | 12,000 0.0766% | $0.91 | $10,920 | +404.92% | ||
| 2024-06-04 | Cittadine Andrew | Chief Operating Officer | 12,000 0.0696% | $0.78 | $9,360 | +473.05% | ||
| 2024-06-03 | Cittadine Andrew | Chief Operating Officer | 12,000 0.0678% | $0.76 | $9,120 | +464.94% |
| Vu Quan Anh | Chief Financial Officer | 1500 0.0223% | $104,835.00 | 1 | 0 | |
| Tsuchimoto Kim R | director | 0 0% | $0 | 1 | 2 | <0.0001% |
| Hendricks Diane | 468750 6.9836% | $32.76M | 1 | 0 | <0.0001% | |
| Tactic Pharma LLC | 10 percent owner | 272026 4.0527% | $19.01M | 1 | 3 | <0.0001% |
| Cittadine Andrew | Chief Operating Officer | 186132 2.7731% | $13.01M | 12 | 0 | |
| Leo Karl | 156250 2.3279% | $10.92M | 1 | 0 | <0.0001% | |
| Radhakrishnan Karthik | Chief Financial Officer | 1550 0.0231% | $108,329.50 | 1 | 0 | +100.9% |
$3,887,391 | 114 | 13.01% | $433.37M | |
$40,226,318 | 58 | 18.89% | $539.26M | |
$16,169,789 | 40 | 7.44% | $485.1M | |
$2,481,409 | 33 | 201.68% | $455.48M | |
$8,866,498 | 28 | 33.64% | $474.26M |
| Increased Positions | 55 | +152.78% | 1M | +32.62% |
| Decreased Positions | 14 | -38.89% | 227,038 | -5.24% |
| New Positions | 22 | New | 584,836 | New |
| Sold Out Positions | 5 | Sold Out | 151,788 | Sold Out |
| Total Postitions | 77 | +113.89% | 6M | +27.38% |
| Janus Henderson Group Plc | $84,979.00 | 18.39% | 1.29M | +115,000 | +9.81% | 2025-09-30 |
| Adage Capital Partners Gp, L.L.C. | $43,513.00 | 9.42% | 659,195 | +60,000 | +10.01% | 2025-09-30 |
| Ra Capital Management, L.P. | $33,745.00 | 7.3% | 511,207 | 0 | 0% | 2025-09-30 |
| Wellington Management Group Llp | $15,279.00 | 3.31% | 231,463 | +231,463 | New | 2025-09-30 |
| Vanguard Group Inc | $13,744.00 | 2.98% | 208,218 | +121,729 | +140.75% | 2025-09-30 |
| Blackrock, Inc. | $13,450.00 | 2.91% | 203,751 | -1,418 | -0.69% | 2025-09-30 |
| Deerfield Management Company, L.P. | $10,546.00 | 2.28% | 159,765 | +159,765 | New | 2025-09-30 |
| Saturn V Capital Management Lp | $10,256.00 | 2.22% | 155,370 | +155,370 | New | 2025-09-30 |
| Tcg Crossover Management, Llc | $10,100.00 | 2.19% | 153,000 | +153,000 | New | 2025-09-30 |
| Adar1 Capital Management, Llc | $8,581.00 | 1.86% | 129,999 | +29,025 | +28.75% | 2025-09-30 |